Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HES vs Ringer's Lactate in Hip Arthroplasty
NCT00542516Phase 4Completed
- Sponsor
- Universidade de São Paulo
- Start
- Sep 2006
- Modality
- Polymer-based Nanoparticles, Lipid-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of hetastarch in hypovolemia (2 arms), sponsored by Universidade de São Paulo. Primary endpoint: HES expansion plasmatic efficacy at 24 hours. Started Sep 2006; status: completed.
02
Drugs
hetastarch
03
Conditions
hypovolemia
Beyond the preview
Go deeper on NCT00542516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00542516.